TS
JAZZ icon

Triglav Skladi’s Jazz Pharmaceuticals JAZZ Stock Holding History

Triglav Skladi’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$269K Buy
+1,115
New +$244K 0.01% 174

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Triglav Skladi's JAZZ Position: Q2 2026 in Review

Triglav Skladi opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1,115 shares worth $269K. The stake represents 0.01% of the portfolio and ranks #174 among its holdings.

641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Triglav Skladi held 1,115 shares of Jazz Pharmaceuticals worth $269K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Triglav Skladi position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Triglav Skladi's portfolio in Q2 2026, its #174 holding.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.